| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 488 | 2019 |
| High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study BK Mahmoodi, MK ten Kate, F Waanders, NJGM Veeger, JLP Brouwer, ... Circulation 117 (2), 224-230, 2008 | 453 | 2008 |
| Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan L Vogt, F Waanders, F Boomsma, D de Zeeuw, G Navis Journal of the American Society of Nephrology 19 (5), 999-1007, 2008 | 424 | 2008 |
| Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CR Swanepoel, MG Atta, VD D’Agati, MM Estrella, AB Fogo, S Naicker, ... Kidney international 93 (3), 545-559, 2018 | 215 | 2018 |
| Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis RHG Olde Engberink, WJ Frenkel, B van den Bogaard, LM Brewster, ... Hypertension 65 (5), 1033-1040, 2015 | 193 | 2015 |
| Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric … F Waanders, VS Vaidya, H van Goor, H Leuvenink, K Damman, ... American journal of kidney diseases 53 (1), 16-25, 2009 | 181 | 2009 |
| Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study BJH Verhaar, D Collard, A Prodan, JHM Levels, AH Zwinderman, ... European heart journal 41 (44), 4259-4267, 2020 | 147 | 2020 |
| Use of a single baseline versus multiyear 24-hour urine collection for estimation of long-term sodium intake and associated cardiovascular and renal risk RHG Olde Engberink, TC van den Hoek, ND van Noordenne, ... Circulation 136 (10), 917-926, 2017 | 108 | 2017 |
| Sodium restriction in patients with CKD: a randomized controlled trial of self-management support Y Meuleman, T Hoekstra, FW Dekker, G Navis, L Vogt, PJM van der Boog, ... American Journal of Kidney Diseases 69 (5), 576-586, 2017 | 105 | 2017 |
| Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease CRC Doorenbos, MM de Cuba, L Vogt, IP Kema, J van den Born, ... The Journal of steroid biochemistry and molecular biology 128 (1-2), 56-61, 2012 | 87 | 2012 |
| Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review WY Van Der Plas, RR Dulfer, AF Engelsman, L Vogt, MH De Borst, ... Nephrology Dialysis Transplantation 32 (11), 1902-1908, 2017 | 81 | 2017 |
| Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis L van der Tol, E Svarstad, A Ortiz, C Tøndel, JP Oliveira, L Vogt, S Waldek, ... Molecular Genetics and Metabolism 114 (2), 242-247, 2015 | 79 | 2015 |
| Role of the vascular wall in sodium homeostasis and salt sensitivity RHGO Engberink, NMG Rorije, JJH van der Heide, BJH van den Born, ... Journal of the American Society of Nephrology 26 (4), 777-783, 2015 | 78 | 2015 |
| Arterial and cellular inflammation in patients with CKD SJB Moens, SL Verweij, FM van der Valk, JC van Capelleveen, J Kroon, ... Journal of the American Society of Nephrology 28 (4), 1278-1285, 2017 | 75 | 2017 |
| Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus–infected middle-aged individuals compared with human immunodeficiency virus … KW Kooij, L Vogt, FWNM Wit, M van der Valk, RA van Zoest, A Goorhuis, ... The Journal of infectious diseases 216 (6), 622-631, 2017 | 74 | 2017 |
| Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study F Amraoui, S Bos, L Vogt, BJ van den Born BMC nephrology 13, 1-6, 2012 | 62 | 2012 |
| SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice F Amraoui, L Spijkers, H Hassani Lahsinoui, L Vogt, J van der Post, ... PloS one 9 (3), e91897, 2014 | 60 | 2014 |
| Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case‐control study F Amraoui, NV Van Der Hoeven, IGM Van Valkengoed, L Vogt, ... The Journal of Clinical Hypertension 16 (2), 122-126, 2014 | 59 | 2014 |
| The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind … L Vogt, G Navis, J Köster, AJ Manolis, JL Reid, D de Zeeuw Journal of hypertension 23 (11), 2055-2061, 2005 | 59 | 2005 |
| Quantification of nonosmotic sodium storage capacity following acute hypertonic saline infusion in healthy individuals RHGO Engberink, NMG Rorije, BJH van den Born, L Vogt Kidney international 91 (3), 738-745, 2017 | 58 | 2017 |
Gerjan NavisInternist, professor of Nutrition in MedicineVerified email at umcg.nl
